What is Bicara Therapeutics's pre-tax income?

Bicara Therapeutics (BCAX) reported pre-tax income of -$56.16M in Q1 2026.

How has Bicara Therapeutics's pre-tax income changed year-over-year?

Bicara Therapeutics's pre-tax income decreased by 52.7% year-over-year, from -$36.77M to -$56.16M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Bicara Therapeutics BCAX Pre-Tax Income

Pre-Tax Income at other companies

Eli LillyLLY

$8.85B+156%

AmgenAMGN

$2.08B+5.6%

Arcus BiosciencesRCUS

-$128M-14.3%

Nuvation BioNUVB

$5.4M+110%

Immunovant, Inc.IMVT

-$150.7M-42.3%

Vir Biotechnology, Inc.VIR

-$125.53M-3.8%

Segments

By segment

See full

Reportable Segment-$56.16M-52.7%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's pre-tax income?: Bicara Therapeutics (BCAX) reported pre-tax income of -$56.16M in Q1 2026.
How has Bicara Therapeutics's pre-tax income changed year-over-year?: Bicara Therapeutics's pre-tax income decreased by 52.7% year-over-year, from -$36.77M to -$56.16M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.